✦ LIBER ✦

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule

✍ Scribed by Steven E. Vogl; Barry H. Kaplan

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 500 KB
Volume: 44
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197907)44:1<26::aid-cncr2820440105>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective chemotherapy for esophageal ca

Effective chemotherapy for esophageal cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II

✍ Steven E. Vogl; Edward Greenwald; Barry H. Kaplan 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 1 views

Mitomycin-C, methotrexate, bleomycin and

Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck

✍ Steven E. Vogl; Harvey Lerner; Barry H. Kaplan; Fernando Camacho; James Cinberg; 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 2 views

Multidrug chemotherapy using bleomycin,

Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin combined with radical radiotherapy in advanced head and neck cancer

✍ Dr. J. Zidan; A. Kuten; Y. Cohen; E. Robinson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

Thirty-one patients with Stage III-IV head and neck squamous cell cancer were treated by three courses of combination chemotherapy using bleomycin, methotrexate, and cisplatin followed by a radical course of radiation and in two cases by surgery. Of 29 evaluable patients, 4 (14%) achieved complete r

Cyclophosphamide, adriamycin, and cis-di

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer

✍ Edward T. Creagan; Thomas R. Fleming; John H. Edmonson; James N. Ingle; John E. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

Combination chemotherapy with methotrexa

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

✍ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot

Chemotherapy for advanced head and neck

Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): Preliminary assessment of a one-day vs. three-day drug regimen

✍ Edward T. Creagan; Thomas R. Fleming; John H. Edmonson; James N. Ingle; John E. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 1 views

Fourteen patients with advanced head and neck carcinomas received a monthly intravenous regimen of Adriamycin, 40 mg/m2, day 1; cyclophosphamide, 400 mg/m2, day 3; and cis-diamminedichloroplatinum, 20 mg/m2/1 hour, days 1-3 (CAP-3). A regression rate of only 7% (0112 squamous cell carcinomas; 112 ad